The drug will be produced at its Hyderabad WHO GMP certified sterile drug product manufacturing plant acquired at an investment of Rs. 75 Crores.
Announcing this strategic partnership Shilpa Reddy, Promoter and Managing Director, Saptagir Laboratories stated “We are honored to partner with Jubilant Generics and make available this life-saving therapy to patients across countries and is a significant step towards saving millions of lives affected by the pandemic.”
“This partnership is timely and in line with our strategic growth plans for the company. Our foray into bulk drug manufacturing will open new revenue streams, backed by our extensive global customer base spanning 50+ countries with an array of products targeted at the fast-growing health and wellness segment.”
#SaptagirLaboratories #ShilpaReddy # Remdesivir #Hyderabad
HyBiz Tv is India’s most-watched Digital Business Channel with over One Million regular viewers. In the 10 years of its existence, HyBiz Tv has provided a platform for business houses to promote, project and propagate their products and services. Corporate videos, promotional videos, interviews, ad- films, events coverage, current relevant news, meaningful discussions on contemporary subjects have given the audience relevant content which has helped in the rapid growth of the viewership. Clients from both the Telugu states and across the country have reaped rich dividends by engaging HyBiz Tv and now this has spread all over the country..
► Watch More Business Videos at India’s Leading online business channel http://www.hybiz.tv
► like us on Facebook: http://www.facebook.com/hybiz
► Watch More Videos on http://www.youtube.com/hybiztv
► Subscribe to HYBIZTV Channel: goo.gl/EEXqfu
►Follow us on Twitter https://twitter.com/hybiztv
The post Saptagir Signs Deal with Jubilant Generics to manufacture Remdesivir | Hybiz Tv appeared first on hybiz.tv.